Is lipoprotein (a) protective of dementia?

European Journal of Epidemiology

Volumn 31, Issue 11, 2016, Pages 1149-1152

  Kunutsor, Setor K ^a   Khan, Hassan ^b   Nyyssönen, Kristiina ^c   Laukkanen, Jari A ^c,d  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

^d Central Finland Central Hospital   (Finland)

Author keywords

Dementia; Lipoprotein(a); Risk factor

Indexed keywords

LIPID; LIPOPROTEIN A;

ALCOHOL CONSUMPTION; DEMENTIA; DIABETES MELLITUS; DISEASE ASSOCIATION; HUMAN; ISCHEMIC HEART DISEASE; LETTER; LIPID BLOOD LEVEL; MEDICAL HISTORY; NEUROPROTECTION; PROTEIN FUNCTION; RISK ASSESSMENT; SMOKING; SOCIAL STATUS; ADULT; BLOOD; FINLAND; FOLLOW UP; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RISK FACTOR;

ADULT; DEMENTIA; FINLAND; FOLLOW-UP STUDIES; HUMANS; LIPOPROTEIN(A); MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84978146261     PISSN: 03932990     EISSN: 15737284     Source Type: Journal    
DOI: 10.1007/s10654-016-0184-0     Document Type: Letter

References (15)

1. Berr C, Wancata J, Ritchie K. Prevalence of dementia in the elderly in Europe. Eur Neuropsychopharmacol. 2005;15(4):463–71. doi:10.1016/j.euroneuro.2005.04.003.
2. Genin E, Hannequin D, Wallon D, et al. APOE and Alzheimer disease: a major gene with semi-dominant inheritance. Mol Psychiatry. 2011;16(9):903–7. doi:10.1038/mp.2011.52.
3. Hobbs HH, White AL. Lipoprotein(a): intrigues and insights. Curr Opin Lipidol. 1999;10(3):225–36.
4. Emerging Risk Factors C, Erqou S, Kaptoge S, et al. Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality. JAMA. 2009;302(4):412–23. doi:10.1001/jama.2009.1063.
5. Breteler MM. Vascular risk factors for Alzheimer’s disease: an epidemiologic perspective. Neurobiol Aging. 2000;21(2):153–60.
6. Solfrizzi V, Panza F, D’Introno A, et al. Lipoprotein(a), apolipoprotein E genotype, and risk of Alzheimer’s disease. J Neurol Neurosurg Psychiatry. 2002;72(6):732–6.
7. Iwamoto T, Watanabe D, Umahara T, Sakurai H, Hanyu H, Kanaya K. Dual inverse effects of lipoprotein(a) on the dementia process in Japanese late-onset Alzheimer’s disease. Psychogeriatrics. 2004;4(3):64–71. doi:10.1111/j.1479-8301.2004.00063.x.
8. Mooser V, Helbecque N, Miklossy J, Marcovina SM, Nicod P, Amouyel P. Interactions between apolipoprotein E and apolipoprotein(a) in patients with late-onset Alzheimer disease. Ann Intern Med. 2000;132(7):533–7.
9. Sarti C, Pantoni L, Pracucci G, et al. Lipoprotein(a) and cognitive performances in an elderly white population: cross-sectional and follow-up data. Stroke. 2001;32(7):1678–83.
10. Kunutsor SK, Laukkanen JA. Gamma glutamyltransferase and risk of future dementia in middle-aged to older Finnish men: a new prospective cohort study. Alzheimer’s Dement J Alzheimer’s Assoc. 2016;. doi:10.1016/j.jalz.2016.03.003.
11. McGeer PL, McGeer EG. The amyloid cascade-inflammatory hypothesis of Alzheimer disease: implications for therapy. Acta Neuropathol. 2013;126(4):479–97. doi:10.1007/s00401-013-1177-7.
12. Loscalzo J. Lipoprotein(a). A unique risk factor for atherothrombotic disease. Arteriosclerosis. 1990;10(5):672–9.
13. Pepe G, Chimienti G, Liuzzi GM, et al. Lipoprotein(a) in the cerebrospinal fluid of neurological patients with blood-cerebrospinal fluid barrier dysfunction. Clin Chem. 2006;52(11):2043–8. doi:10.1373/clinchem.2006.073544.
14. Saczynski JS, White L, Peila RL, Rodriguez BL, Launer LJ. The relation between apolipoprotein A-I and dementia: the Honolulu-Asia aging study. Am J Epidemiol. 2007;165(9):985–92. doi:10.1093/aje/kwm027.
15. Boyles JK, Zoellner CD, Anderson LJ, et al. A role for apolipoprotein E, apolipoprotein A-I, and low density lipoprotein receptors in cholesterol transport during regeneration and remyelination of the rat sciatic nerve. J Clin Invest. 1989;83(3):1015–31. doi:10.1172/JCI113943.